Evidence map›Paper›PMID 39574946›Full record

ArticleArchives of internal medicine research2024

Etiology, Pathophysiology, and Treatment Strategies in the Prevention and Management of Metabolic Syndrome.

Ritika Patial, Irene Batta, Manish Thakur, Ranbir Chander Sobti, Devendra K Agrawal

Abstract read
In one paragraph

Article in Archives of internal medicine research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Diallyl trisulfide attenuates metabolic syndromeFrontiers in pharmacology · 2026
    Article
  15. Article
  16. Frontiers in nutrition · 2026
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ritika PatialCentre for System Biology & Bioinformatics, Panjab University, Chandigarh, India.
Irene BattaBothell High School, Bothell, Washington, USA.
Manish ThakurSchool of Bioengineering & Biosciences, Lovely Professional University, Phagwara, Punjab, India.
Ranbir Chander SobtiDepartment of Biotechnology, Panjab University, Chandigarh, India.
Devendra K AgrawalDepartment of Translational Research, Western University of Health Sciences, Pomona, California, USA.

Funding

Novel Approach to Stabilize Atherosclerotic Plaque in Carotid ArteryR01HL144125 · NHLBI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI AGRAWAL, DEVENDRA K. · 2018 to 2021
$2.8M
Novel Molecular Target to Prevent Maturation Failure of Arteriovenous FistulaR01HL147662 · NHLBI · WESTERN UNIVERSITY OF HEALTH SCIENCES · PI AGRAWAL, DEVENDRA K. · 2019 to 2022
$2.8M
NHLBI NIH HHS R01 HL144125NHLBI NIH HHS R01 HL147662
6 · The paper itself

Abstract

Metabolic Syndrome (MetS) is a complex cluster of metabolic irregularities that significantly increase the risk of developing chronic conditions, such as hypertension, type 2 diabetes, cardiovascular diseases, and other related disorders. This review aims to provide a comprehensive overview of the current understanding of MetS, its etiology and underlying pathogenesis, and the management strategies. MetS is characterized by central obesity, high blood pressure, insulin resistance, hyperglycemia, hypertriglyceridemia, and low high-density lipoprotein cholesterol levels. The prevalence of MetS is remarkably high, affecting approximately 25% of the global population, particularly in developed nations with inactive lifestyles and high-calorie diets. The development of MetS involves genetic and acquired factors, resulting in an inflammatory state that enhances the risk for cardiovascular disease. The biochemical alterations observed in MetS establish pathological connections between MetS, diabetes, and cardiovascular and neurodegenerative conditions. Despite its clinical importance, there is still debate regarding the precise components and pathophysiological associations among MetS elements. However, advancements in therapeutic measures, including drug therapies, surgical options, and experimental methods present promising avenues for managing and potentially reversing MetS. Further investigation of the MetS is critical because of its significant implications for public health and its connection to other clinical conditions and severe health outcomes, placing a substantial burden on healthcare system and society.

Indexed as

Cardiovascular diseasesInflammationInsulin resistanceLipid metabolismMetabolic SyndromeObesityType 2 diabetes

Identifiers

PMID39574946
PMCPMC11580789

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.